Mantle cell lymphoma: are current therapies changing the course of disease?
Mantle cell lymphoma (MCL) is a rare entity of non-Hodgkin's lymphoma, although it seems to be increasing in incidence and severity. There is no accepted standard therapy; however, one controlled clinical trial demonstrated that intensive induction immunochemotherapy followed by high-dose radiochemotherapy and autologous stem cell transplantation was superior to conventional treatment. Moreover, uncontrolled studies of intensive immunochemotherapy followed by autologous stem cell transplantation now suggest that MCL may be cured. Insight into the biology of MCL is expanding, opening new avenues of treatment with well-defined molecular targets, including CD20, mammalian target of rapamycin, and proteasomes.
Geisler
Christian
C
Department of Hematology 4042, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. Christian.geisler@rh.regionh.dk
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods*; D033581:Stem Cell Transplantation / Q000379:methods*; D016019:Survival Analysis; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D000970:Antineoplastic Agents
Bone Marrow Transplant. 2009 Mar;43(6):509-11
18955979
Curr Opin Hematol. 2007 Nov;14(6):632-8
17898567
J Clin Oncol. 2005 May 20;23(15):3383-9
15908650
Bone Marrow Transplant. 2007 Dec;40(11):1007-17
17922042
Br J Haematol. 2009 Feb;144(4):524-30
19036081
Br J Haematol. 2005 Oct;131(1):29-38
16173960
J Clin Oncol. 2000 Jan;18(2):317-24
10637245
Nat Rev Cancer. 2007 Oct;7(10):750-62
17891190
J Clin Oncol. 2005 Mar 20;23(9):1984-92
15668467
J Natl Cancer Inst. 2007 May 2;99(9):706-14
17470738
Blood. 2004 Nov 15;104(10):3064-71
15284112
Blood. 2004 Dec 1;104(12):3535-42
15304387
Hematol Oncol. 2009 Sep;27(3):154-9
19274614
J Clin Oncol. 2005 Oct 1;23(28):7013-23
16145068
Blood. 1996 Jun 1;87(11):4483-94
8639814
J Clin Oncol. 2009 Feb 1;27(4):511-8
19075279
Blood. 2008 Jan 15;111(2):558-65
17962512
Blood. 2006 Dec 15;108(13):4003-8
16946304
J Clin Oncol. 2005 Aug 10;23(23):5347-56
15983389
J Clin Oncol. 2002 Mar 1;20(5):1288-94
11870171
J Clin Oncol. 2005 Feb 1;23(4):705-11
15598978
Blood. 2008 Oct 1;112(7):2687-93
18625886
Invest New Drugs. 2009 Oct;27(5):476-81
18953490
Eur J Haematol. 2003 Aug;71(2):73-80
12890145
Bone Marrow Transplant. 1998 Oct;22(7):645-50
9818691
Cancer. 2008 Aug 15;113(4):791-8
18615506
Am J Surg Pathol. 2006 Oct;30(10):1274-80
17001159
Leukemia. 2002 Apr;16(4):587-93
11960337
J Clin Oncol. 1998 May;16(5):1922-30
9586911
J Clin Oncol. 2009 Mar 10;27(8):1209-13
19188674
J Clin Oncol. 2008 Jan 1;26(1):90-5
18025438
Blood. 1997 Jun 1;89(11):3909-18
9166827
J Clin Oncol. 2008 Mar 20;26(9):1544-52
18285605
Blood. 2008 Feb 15;111(4):2385-7
18077791
Cancer. 2008 Aug 1;113(3):508-14
18543327
Leuk Lymphoma. 2009 Mar;50(3):463-5
19197732
Br J Haematol. 2009 Apr;145(1):34-9
19220284
J Clin Oncol. 1998 Dec;16(12):3803-9
9850025
Blood. 2009 Apr 30;113(18):4144-52
19168784
Blood. 2005 Apr 1;105(7):2677-84
15591112
Haematologica. 2007 Jan;92(1):42-9
17229634
Biol Blood Marrow Transplant. 2006 Dec;12(12):1270-6
17162208
Ann Oncol. 2009 Mar;20(3):520-5
19074748
Br J Haematol. 2009 May;145(3):344-9
19245430
J Clin Oncol. 2008 Oct 20;26(30):4966-72
18606985